Implantable Cardioverter Defibrillator Market Size, Share and Industry Analysis By Product Type (Transvenous ICD, Subcutaneous ICD), End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Regional Forecast, 2020 - 2029 (Includes COVID-19 Business Impact)

                                          
We have updated Implantable Cardioverter Defibrillator Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Implantable Cardioverter Defibrillator market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Implantable Cardioverter Defibrillator market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Implantable Cardioverter Defibrillator Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Implantable Cardioverter Defibrillator Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Implantable Cardioverter Defibrillator Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
Medtronic
  
Boston Scientific Corporation
  
Biotronik
  
LivaNova Plc
  
Abbott
  
Microport
  
Other prominent players

Report Overview

Implantable cardioverter defibrillator (ICD) offers an effective treatment option to deal with sudden cardiac arrest and arrhythmia. ICD plays a major role in detecting irregular heart rhythm and to provide effective electric shocks with the aim to regularize the heartbeat. The rapidly increasing prevalence of sudden cardiac deaths and unmet demand in emerging nations are expected to drive the implantable cardioverter defibrillator market growth by 2026.
The report provides qualitative and quantitative insights on the implantable cardioverter defibrillator industry and detailed analysis of market size and growth rate for all possible segments in the market. The market is segmented by product, by the end user, and by region. On the basis of the product type, the implantable cardioverter defibrillator market is segmented into transvenous ICD and subcutaneous ICD.

Transvenous ICD is further segmented as single chamber ICD, dual chamber ICD, and CRT-D (cardiac resynchronization therapy- defibrillator). Various end users covered under the report are hospitals & clinics and ambulatory surgery centers and others. Geographically, the market is segmented into four major regions, which are North America, Europe, Asia Pacific, and the rest of the World. The regions are further categorized into countries.
Along with this, the report provides elaborative analysis of the market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of sudden cardiac arrests in key countries, technological advancements in implantable cardioverter defibrillators, recent industry developments such as mergers & acquisitions, the regulatory scenario in key countries, new products launches, reimbursement scenario, and key industry trends.

SEGMENTATION

By Product Type

  
      Transvenous ICD
  
         Single Chamber ICD
  
         Dual Chamber ICD
  
         CRT-D (cardiac resynchronization therapy- defibrillator)
  
      Subcutaneous ICD

By End User

  
      Hospitals & Clinics
  
      Ambulatory Surgery Centers and Others

By Geography

  
      North America (USA and Canada)
  
      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
      Rest of the World

Key Industry Developments

In April 2019, Biotronik launched a newly developed implantable defibrillator of the Acticor series. Newly launched devices have less leads, reduced procedure time as well as reduced costs.

In February 2015, Boston Scientific Corporation launched Extended Longevity Implantable Defibrillators, which are comprised of EnduraLife battery technology. This technology offers extended battery life for the defibrillator, resulting in a reduction of replacements and maintenance.

In December 2016, Boiotronik launched Ulta-high energy defibrillators in the U.S. market for the treatment of heart failure.